- Received November 30, -0001
- Accepted November 30, -0001
- Publication December 18, 2019
- Visibility 7 Views
- Downloads 0 Downloads
- DOI 10.18231/j.ijirm.2019.057
-
CrossMark
- Citation
Left ventricular diastolic and pulmonary dysfunction in patients with sub-clinical hypothyroidism; A case- control study
- Author Details:
-
Amira H Allam *
-
Mohamed S Darwish
Introduction
Hypothyroidism is the most common form of thyroid disorder throughout the world.[1] Subclinical hypothyroidism is a common endocrine disorder characterized by increased levels of thyroid stimulating hormone (TSH) with normal levels of free thyroxine (T4) and free triiodothyronine (T3) in serum. The signs and symptoms of SCH are usually subtle as compared with those of overt hypothyroidism, so it is difficult to detect. Thus, the diagnosis of SCH is a laboratory diagnosis.[2] As the values of thyroid hormone are normal, increased level of TSH represents a compensatory mechanism that stimulates the thyroid gland to produce sufficient amounts of thyroid hormones. The disorder can eventually progress to overt hypothyroidism which is characterized by increased values of TSH but reduced values of thyroid hormones.[3] The range of TSH for diagnosis of SCH is between 4.5 mIU /L-10 mIU /L. A study including 107 SCH patients reported progression to full blown hypothyroidism in 26.8% with higher TSH levels being a significant indicator.[4] However, a study reported 52% of SCH patients with TSH below 10, spontaneously recovered.[5] The prevalence of this condition in different population studies varied from 1% to 17%, with the highest prevalence in the elderly.[6]
The risk that subclinical hypothyroidism will progress to overt hypothyroidism in patients with TSH higher than 8 mIU /L is high, and in 70% of these patients, the TSH level rises to more than 10 mIU /L within 4 years. Early treatment should be considered if the TSH is higher than 7 or 8 mIU /L.[7]
Subclinical hypothyroidism has been associated with adverse metabolic, cardiovascular, neuromuscular, and cognitive effects and has been shown to have a detrimental impact on quality of life.[8] Mild and subclinical thyroid dysfunction is associated with an increased mortality in patients with cardiovascular disease.[9],[10],[11] A report indicated that patients with SCH (median 6.3 mIU /l) and pre-existing heart failure had a higher rate of mortality as compared with euthyroid candidates.[12]
The Respiratory system like other body systems and organs is affected by hypothyroidism though respiratory manifestations are seldom the major complaints in hypothyroidism.[13] Both hypothyroidism and hyperthyroidism cause respiratory muscle weakness and decrease pulmonary function. Lung volumes are usually normal, but studies have shown findings suggestive of restrictive pattern of impairment.[14]
This study was carried out with the objective to evaluate the left ventricular diastolic dysfunction in individuals with subclinical hypothyroidism. Also, to evaluate the relation between left ventricular diastolic dysfunction indices and thyroid hormones with some pulmonary function parameters (FEV1%, FVC%, FEF 25-75%).
Materials and Methods
This study was a case control study which was carried out in the period from February 2018 to August 2019. Ninety- five (95) subjects were enrolled in the study selected from those who visited Benha University hospital outpatient general Clinic for checkup. They were divided into 2 groups; 50 cases (group 1) and 45 controls (group 2).
Inclusion criteria
Higher than upper limit of normal TSH (> 4.5 mU /L) but lower than 10 m U /L as this defines subclinical hypothyroidism state.
Normal levels of thyroxin (FT4) (9–16 pmol /L, and normal free triiodothyronine (FT3) level (3.7–6.5 pmol /L).
Age between 20 and 60 years (as above 60 years diastolic dysfunction can be present even in healthy subjects.[15]
Exclusion criteria
1. Absence of diabetes mellitus, hypertension, cardiac respiratory, liver or kidney disease. They were excluded by thorough history taking and necessary investigations.
2. Absence of smoking, alcoholism or drugs that affect the thyroid, cardiac or pulmonary function.
Control subjects were selected from age, sex and BMI matched healthy volunteers who were subjected to the same selection criteria as cases but with TSH level within normal range (0.4 to 4.2 m U /L).
This research was accepted by research ethics committee of Faculty of medicine, Benha University. All procedures performed in this study were in accordance with the ethical standards of the institutional and / or national research committee and with Helsinki declaration and its later amendments.
In both groups the following was performed:
Assessment of thyroid function
This was done in two occasions; at the beginning of the study and 6 weeks later. After an overnight fasting venous blood was withdrawn from both cases and controls. TSH, FT4 and FT3 were assayed using ELIZA reader (450 nm). The three thyroid hormones kits were supplied by Genzyme Diagnostics (1531, Industrial road, San Carlos, CA 94070 U.S.A).
Assessment of left ventricular diastolic dysfunction
Examination was done by a single cardiologist who was blinded about the study subject state (cases vs controls). A commercially available (Vivid 7; General Electric, Vingmed, Norway) echocardiography system was used in the study. At apical four chamber view a pulsed‑wave Doppler was used to measure trans-mitral flow velocity. Diastolic trans-mitral peak velocity (E and A wave), E/A ratio, and deceleration time (DT) of mitral E wave were measured. At apical five‑chamber view, continuous‑wave Doppler was used to obtain IVRT, we took the average value of three consecutive beats to get the final value. Diastolic dysfunction was diagnosed if any of the following was present: (a) E/A ≤1.0, (b) IVRT ≥ 100 ms, or (c) DT ≥220 ms.[16]
Assessment of pulmonary function parameters
Examination was done by a single pulmonologist who was blinded about subject state (cases versus controls). Room temperature and pressure were entered along with the patient data [age (years), weight (kg), height (cm), and sex] to obtain results in the form of percent of-predicted (% predicted) except for FEV1 /FVC. A Sensor-medics Vmax series, 2130 spirometer, V 6200 Autobox, 6200 DL (Sensor Medics Corporation, California, USA) was used in the study. Flow/volume loop was performed to all participants. Individuals with FEV1 /FVC less than 0.7 of predicted were excluded from the study.
Statistical analysis
The collected data were analyzed using SPSS version 18 for windows (IBM corporation, Chicago, USA). Quantitative variables were displayed as means and standard deviations. Independent T test was used to compare cases and control groups while Chi square test was used to compare qualitative variables. For correlation between variables, Pearson correlation co-efficient was used (r), P < 0.05 was considered significant statistically.
Results
This work was carried out on 95 subjects divided into; group 1 which included 50 patients with higher than normal TSH (subclinical hypothyroid group) and group 2 which included 45 healthy subjects with a normal TSH level as control. [Table 1] showed a well-matched age and BMI between both groups. However, systolic and diastolic blood pressures were higher in group 1 than group 2 but still in the normal range for BP. in both groups the number of females were higher than males (P value 0.000).
| Group 1 (N =50) | Group 2 (N= 45) | P value | |
| Age | 48.46±6.12 | 47.93±6.42 | 0.68 |
| Sex Males females | 21 29 | 19 26 | .000 .000 |
| BMI | 31.51±2.79 | 31.35±2.93 | 0.79 |
| Systolic BP | 136.96±5.58 | 131.42±10.06 | 0.002 |
| Diastolic BP | 83.1±4.96 | 79.02±5.306 | .000 |
| total | 50 | 45 | 95 |
In [Table 2] despite FT3 and FT4 levels were normal in both groups, TSH was significantly higher in group 1 (P value 0.000). FT3 despite of being in the normal range, it was lower in group 1 (2.61±0.82) than in group 2 (3.61±0.74) P value 0.000. echocardiographic measurements have shown diastolic dysfunction in group 1 where peak E velocity was reduced (57.53±11.48 VS 71.43±3.69 In group 2) while peak A velocity was increased (67.30±4.61) compared to group 2 (54.81±8.22) P value 0.000. as a result, E/ ratio was found to be lower in group1 (0.85±0.18) compared to (1.54±1.73) in group 2 (p value 0.012). IVRT and DT were significantly longer in group 1 (119.51±4.70, 174.18±8.41 Respectively) than group 2 (70.26±4.43, 164.34±6.34 Respectively) (P value 0.000) pulmonary functional indices (FEV1, FVc, FEF25-75)% were all significantly lower in group 1 than in group 2 (P value 0.012, 0.000, 0.001 respectively). There were no gender differences in all the measured variables except for FVC which was lower in males than females in group 1 (P value 0.012). TSH was mildly lower in males than females in group 2 but the difference was not highly significant P value (0.047), [Table 3].
| Group 1 (N=50) | Group 2 (N=45) | P value | |
| TSH | 6.35±1.58 | 2.79±0.85 | .000 |
| T3 | 2.61±0.82 | 3.61±0.74 | .000 |
| T4 | 12.55±1.81 | 12.68±1.74 | 0.727 |
| Peak E velocity | 57.53±11.48 | 71.43±3.69 | .000 |
| Peak A velocity | 67.30±4.61 | 54.81±8.22 | .000 |
| E/A ratio | 0.85±0.18 | 1.54±1.73 | .012 |
| IVRT | 119.51±4.70 | 70.26±4.43 | .000 |
| DT | 174.18±8.41 | 164.34±6.34 | .000 |
| FEV1% | 81.74±6.30 | 84.6±5.71 | .021 |
| FVC% | 83.3±4.76 | 88.53±4.05 | .000 |
| FEF25-75% | 73.85±18.69 | 83.76±6.19 | .001 |
| Total | 50 | 45 | 95 |
| Group 1 | P value | Group 2 | P value | |||
| Males | Females | Males | Females | |||
| TSH | 6.09±1.32 | 6.54±1.74 | .298 | 2.505±0.75 | 3.01±0.88 | .047 |
| E wave velocity | 58.05±12.76 | 57.15±10.67 | .794 | 71.43±3.17 | 71.43±4.08 | .997 |
| A wave velocity | 66.46±5.13 | 67.89±4.18 | .298 | 55.27±3.79 | 54.47±10.40 | .719 |
| E/A ratio | 0.87±0.20 | 0.85±0.17 | .594 | 1.30±0.11 | 1.71±2.28 | .364 |
| DT | 175.13±8.71 | 173.45±8.26 | .507 | 164.37±5.76 | 164.31±6.84 | .974 |
| IVRT | 118.38±5.38 | 120.32±4.03 | .172 | 70.35±3.51 | 70.18±5.07 | .896 |
| FEV1% | 81.10±5.87 | 82.21±6.67 | .536 | 85.05±5.97 | 84.31±3.77 | .674 |
| FVC% | 81.19±5.44 | 84.83±3.57 | .012 | 88.63±4.49 | 88.46±3.79 | .894 |
| FEF25-75% | 78.24±4.12 | 70.68±23.96 | .106 | 83.89±6.34 | 83.65±6.20 | .900 |
TSH level was correlated with many of the study variables where it had a negative correlation with E wave velocity, E/A ratio and the three pulmonary function indices while it showed a strong positive correlation with IVRT (P value 0.000), [Table 4]. IVRT also has a moderate negative correlation with FVC% (r .487 p value 0.000). However, correlations between other echocadiograpic parameters of LV dysfunction and pulmonary function indices were weak, [Table 5].
| TSH | T3 | T4 | ||||
| r | P | r | P | r | P | |
| E wave velocity | -.435 | 0.000 | -0.111 | 0.420 | -0.018 | 0.898 |
| A wave velocity | .549 | 0.000 | -0.305 | 0.030 | -0.138 | 0.338 |
| E/A ratio | -.242 | 0.018 | -0.018 | 0.899 | 0.031 | 0.829 |
| DT | .455 | 0.000 | 0.008 | 0.957 | 0.228 | 0.111 |
| IVRT | .796 | 0.000 | 0.124 | 0.392 | 0.138 | 0.339 |
| FEV1% | -.154 | .137 | -0.124 | 0.390 | -0.0819 | 0.572 |
| FVC% | -.360 | 0.000 | -0.031 | 0.828 | -0.0585 | 0.686 |
| FEF25-75% | -.234 | .023 | -0.063 | 0.660 | 0.152 | 0.294 |
| E wave velocity | A wave velocity | E/A ratio | DT | IVRT | ||||||
| r | P | r | p | r | P | r | P | r | P | |
| FEV% | .161 | .119 | -.112 | 0.240 | .099 | 0.342 | -.112 | 0.281 | -.218 | 0.034 |
| FVC% | .383 | 0.000 | -.251 | .014 | .092 | .374 | -306 | 0.003 | -.487 | 0.000 |
| FEF25-75% | .172 | 0.096 | -.189 | .067 | .089 | .392 | -.251 | 0.014 | -.329 | 0.001 |
Discussion
The heart is very sensitive to alterations in serum thyroid levels.[17] Nonspecific histologic abnormalities have been demonstrated repeatedly in the hearts of myxoedema patients since first reported in 1888 in a report of a committee of the Chemical Society of London.[18]
It is known that clinically manifest hypothyroidism is associated with systolic and diastolic left ventricular disfunction.[17] However, studies investigating the systolic and diastolic function of the heart in SCH showed controversial results.[19]
In the current work, echocardiograpic measurements have shown diastolic dysfunction in group 1 where peak E velocity was reduced while peak A velocity was increased compared to group 2. As a result, E/ ratio was found to be lower than 1 (0.85±0.18) in group 1. IVRT and DT were significantly longer in group 1 than group 2. This was similar to a study done by Biondi et al.,[20] Kosar et al.,[21] Franzoni et al.,[22] and Nag et al.[23] However, the latter had measured Tei index and found a higher index in the sub-clinical hypothyroidism group. In contrast to our study and the study done by Kosar et al., and Biondi et al., NAg et al., found no prolongation of E wave velocity. Vitale et al.[24] Despite he did not find alterations in the above parameters they had diagnosed diastolic dysfunction in 20 subclinical hypothyroidism patients by increases in LV preejection period, preejection period/LV ejection time ratio, and isovolumic relaxation time (IVRT). Meena., et al., [25] investigated 30 subjects with subclinical hypothyroidism with tissue doppler echocardiography. They found a decreased E wave velocity with decreased E/A ratio. Arnic et al., [26] diagnosed diastolic dysfunction based on the significantly higher Septal annulus relaxation time in SCH group. Lateral annulus and myocardial relaxation times, precontraction /contraction ratios and precontraction times were also slightly higher. Septal, lateral annulus and lateral myocardial relaxation times were decreased after TRT.
In the current study TSH was moderately correlated negatively with E wave velocity while moderately correlated positively with IVRT and DT. T3 was moderately correlated with A wave velocity, in all the above correlations P value was significant. Malhotra et al.,[27] studied 67 patients with SCH by echocardiography. Their results showed that E/A ratio correlated significantly with thyroid stimulating hormone (TSH), free triiodothyronine (FT3) with echocardiographic indices for LVDD showed significant improvement after 6 months of L-thyroxine therapy. In Vitale et al. [24] Study, Myocardial precontraction time (PCTm) and myocardial relaxation time (RTm) were prolonged and PCTm/myocardial contraction time ratio was increased and positively correlated to serum TSH levels.
In the absence of primary respiratory disease, the diminution of the respiratory function in the hypothyroid patients is not significant in most cases. Nevertheless, it does affect the respiratory system including respiratory muscle weakness, alveolar hypoventilation due to decreased hypoxic and hypercapnic ventilatory drives, upper airway obstruction, central and obstructive sleep apnea and even pleural effusion. Lung volumes are usually normal or mildly reduced, but maximal breathing capacity and diffusing capacity are usually reduced.[27] Though there are many literatures regarding the effect of hypothyroidism on pulmonary function, few studies revealing the influence of subclinical hypothyroidism on pulmonary functions are found.[28]
In our study FEV1%, FVC%, FEF25-75% though still in the normal range they were significantly lower in group 1 with moderate negative correlation between FVC and TSH however no significant correlation between the measured pulmonary function parameters and left ventricular diastolic dysfunction parameters except FVC and IVRT where there was a moderate negative correlation. Sutar and Mishra[29] compared spirometry in 70 subjects with subclinical hypothyroidism and 35 control ones, they found abnormal spirometry in 26% (18 out of 70) patients had abnormal spirometry findings. The most common spirometric abnormality was mild restrictive pattern i.e. decreased FVC% and FEV1% and increased FEV1/FVC%. This coincides with a study conducted by Valjevac et al.[30] who suggested that the causes for reduced respiratory function are decreased inspiratory muscle strength, hypoventilation, hypercapnia and it is related to the degree and duration of the thyroid disorders in hypothyroidism. Another study conducted by Cakmak et al[31] found a significantly lower FVC, FEV1, FEF25-75% and diffusing capacity of lung for carbon monoxide (DLCO) in patients with subclinical hypothyroidism. FEF25 -75% is an average Forced Expiratory Flow rate over the middle 50% of the FVC and it is said to be more sensitive than FEV1 for detecting early airway obstruction.[32] Cakmak et al (2007)[33][31] reported a significant decrease in FEF25-75% in subclinical hypothyroidism patients, this was in accordance with our study results. In our study, FEF 25-75% was weakly correlated with thyroid hormones and cardiac diastolic dysfunction parameters. In Contrary, Sutar and Mishra, [29] Sharon et al, [34] didn’t find a significant decrease in FEF 25-75% in patients of SCH. They explained their results by the assumption that this parameter reflects a slowing in terminal part of airways. So, in their study they presumed no small airway obstruction in subclinical hypothyroids.
Conclusion
Sub-clinical hypothyroidism patients are more prone to left ventricular diastolic dysfunction. So, they should be screened by doppler echocardiography for early diagnosis and management. Although the pulmonary function alterations in sub-clinical hypothyroidism are mild, they should not be ignored. Further studies are needed to decide whether these changes are enough to establish thyorxine replacement therapy.
Conflicts of interest
None
Acknowledgments
None
References
- . M N J Strachan, J. Newell Price: 2014 Davidson Principle & Practice Of Internal Medicine 22nd edi; © Churchill Livingstone chp 20;p.74. . [Google Scholar]
- G R Wilson, R W Curry, . Subclinical thyroid disease. Am Fam Physician J 2005. [Google Scholar]
- M Coji, L Cvejanov-Kezunovi. Subclinical Hypothyroidism - Whether and When To Start Treatment? Open Access Maced. J Med Sci 2017. [Google Scholar]
- J Dez, P Iglesias. Spontaneous Subclinical Hypothyroidism in Patients Older than 55 Years: An Analysis of Natural Course and Risk Factors for the Development of Overt Thyroid Failure. The J Clin Endocrinol Metab 2004. [Google Scholar]
- B Åsvold, L Vatten, T Nilsen, T Bjro. The association between TSH within the reference range and serum lipid concentrations in a population-based study. Eur J Endocrinol 2007. [Google Scholar]
- AP. Hypothyroidism: screening and subclinical disease. BMJ 1997. [Google Scholar]
- Sizra Azim, Christian Nasr. Subclinical hypothyroidism: When to treat. Cleve Clin J Med 2019. [Google Scholar] [Crossref]
- C Baumgartner, M R Blum, N Rodondi. Subclinical hypothyroidism: summary of evidence. Swiss Med Wkly 2014. [Google Scholar]
- G Iervasi, S Molinaro, P Landi. Association between increased mortality and mild thyroid dysfunction in cardiac patients. Arch Intern Med 2007. [Google Scholar]
- M Schultz, C Kistorp, I Raymond, J Dimsits, C Tuxen, P Hildebrandt. Cardiovascular events in thyroid disease: a population based, prospective study. Horm Metab Res 2011. [Google Scholar]
- J L Johnson. Diabetes control in thyroid disease. Diabetes Spectrum 2006. [Google Scholar]
- G Canaris, N Manowitz, G Mayor, E Ridgway. The Colorado Thyroid Disease Prevalence Study. Arch Internal Med 2000. [Google Scholar]
- L E Braverman, R D Utiger, L E Braverman, R D Utiger, S C Werner. Introduction to hypothyroidism. The thyroid: Afundamental and clinical text. 9th Ed. 2005. [Google Scholar]
- H Valtin, S Tenney. Respiratory adaptation to hyperthyroidism. J Appl Physiol 2009. [Google Scholar]
- S Razvi, J U Weaver, M P Vanderpump, S H Pearce. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: Reanalysis of the Whickham Survey cohort. J Clin Endocrinol Metab 2010. [Google Scholar]
- H Rakowski, C Appleton, K L Chan, J G Dumesnil, G Honos, J Jue. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: From the investigators of consensus on diastolic dysfunction by echocardiography. J Am Soc Echocardiogr 1996. [Google Scholar]
- I Klein, K Ojamaa. Thyroid hormone and the cardiovascular system. N Eng J Med 2001. [Google Scholar]
- E W Bough, W F Crowley, C E Ridgway. Myocardial function in hypothyroidism - relation to disease severity and response to treatment. Arch Intern Med 1978. [Google Scholar]
- D A Bemben, R M Hamm, L Morgan, P Winn, A Davis, E Barton. Thyroid disease in the elderly. Part 2. Predictability of subclinical hypothyroidism. J Fam Prac 1994. [Google Scholar]
- B Biondi, S Fazio, E A Palmieri, C Carella, N Panza, A Cittadini. Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J Clin Endocrinol Metab 1999. [Google Scholar]
- F Kosar, I Sahin, N Turan, E Topal, Y Aksoy, C Taskapan. Evaluation of right and left ventricular function using pulsed-wave tissue Doppler echocardiography in patients with subclinical hypothyroidism. J Endocrinol Invest 2005. [Google Scholar]
- F Franzoni, F Galetta, P Fallahi, L Tocchini, G Merico, L Braccini. Effect of L-thyroxine treatment on left ventricular function in subclinical hypothyroidism. Biomed Pharmacother 2006. [Google Scholar]
- C 23- Nag, B C Seth, S K Haldar. Diastolic dysfunction in subclinical hypothyroid patients in rural India: A case-control study. Nig J Cardiol 2016. [Google Scholar]
- G Vitale, M Galderisi, G A Lupoli, A Celentano, I Pietropaolo, N Parenti. Left ventricular myocardial impairment in subclinical hypothyroidism assessed by a new ultrasound tool: Pulsed tissue Doppler. J Clin Endocrinol Metab 2002. [Google Scholar]
- C L Meena, R D Meena, R Nawal. Assessment of left ventricular diastolic dysfunction in sub-clinical hypothyroidism. Acta Inform Med 2012. [Google Scholar]
- H Arinc, H Gunduz, A Tamer. Tissue Doppler echocardiography in evaluation of cardiac effects of subclinical hypothyroidism. Int J Cardiovasc Imaging 2006. [Google Scholar]
- Y Malhotra, R M Kaushik, R Kaushik. Echocardiographic evaluation of left ventricular diastolic dysfunction in subclinical hypothyroidism: A case-control study. Endocrinal Res 2017. [Google Scholar] [Crossref]
- Ramachandran, N S Chidambaram, S Periyasamy, R Santhaprabu. Spirometric assessment of pulmonary functions in adult with documented primary hypothyroidism. IAIM 2016. [Google Scholar]
- S B Sutar, S Mishra. Pulmonary Function Testing in patients with subclinical hypothyroidism: A study from eastern India. India J Appl Res 2019. [Google Scholar]
- S Valjevac, A Hadzovic-Dzuvo, A Valjevac, E Kucukalic -Selimovic, O Lepara. Assesement of lung dysfunction with spirometry in patients with thyroid Disorders. Acta Inform Med 2011. [Google Scholar]
- G Cakmak, T Saler, Z Saglam, M Yenigen, T Demir. Spirometry in Patients with clinical and subclinical hypothyroidism. Tberklozve Toraks Dergisi 2007. [Google Scholar]
- E Hyatt Robert, D Scanlon Paul, Nakamura Masao. Interpretation of Pulmonary Function Tests 2nd ed. Mayo foundation for medical education and research. 2014. [Google Scholar]
- S Roel, O Punyabati, L Prasad, R Salam, K Ningshen, A J Shimray. Assessment of Functional Lung Impairment in Hypothyroidism. IOSR J Dent Med Sci . [Google Scholar]